Skip to main content

Month: July 2025

NewtekOne, Inc. Upsizes Additional Warehouse Facility to Support Growth of ALP Business

BOCA RATON, Fla., July 29, 2025 (GLOBE NEWSWIRE) — NewtekOne, Inc. (“NewtekOne”) (NASDAQ: NEWT) announced that its consolidated subsidiary, Newtek ALP Holdings, amended its revolving credit facility with Capital One, N.A. (“Capital One”), which is employed to fund the origination of Alternative Loan Program (“ALP”) loans before they are placed into securitizations. The amendment provides for, among other things, a facility increase from $60 million to $100 million and a maturity extension of two years. The amended and extended Capital One facility comes on the heels of the Deutsche Bank ALP facility being amended in June. Barry Sloane, Chairman, President, and Chief Executive Officer, commented, “Our borrowing relationship with Capital One extends back almost 15 years. Capital One has been a great partner, helping NewtekOne to...

Continue reading

3D Systems Announces Major Milestone in Digital Dentistry with Full Commercial Release of New FDA-cleared Denture Solution

3D Systems’ Jetted Dentures for Patients3D Systems’ first-to-market solution for multi-material, monolithic jetted dentures enables a durable, long-wear, aesthetically beautiful prosthetic for patients.Dentures produced using 3D Systems’ Jetted Denture Solution3D Systems’ Jetted Denture Solution utilizes multiple materials in a single printing process resulting in a faster, more cost-effective and highly scalable alternative to traditional denture fabrication.Company’s technology redefines dental prosthetics with revolutionary single-piece, multi-material dentures delivering distinctive combination of exquisite aesthetics, comfort and outstanding resistance to breakage for enhanced patient experience NextDent® Jetted Denture Solution validated with strong endorsements from beta customers highlighting effortless...

Continue reading

iPower Inc. Advances Digital Asset Strategy and E-Commerce Platform Development

Company Prepares Digital Asset Treasury Strategy with Yield and Expands Digital Asset Product Pipeline RANCHO CUCAMONGA, Calif., July 29, 2025 (GLOBE NEWSWIRE) — iPower Inc. (NASDAQ: IPW), a data and technology driven e-commerce retailer and infrastructure company, today announced further developments in its digital asset strategy and technology initiatives. These efforts are part of iPower’s long-term roadmap to integrate blockchain capabilities across treasury operations, consumer offerings, and future commerce infrastructure. “We believe the future of commerce will be deeply integrated with digital assets. iPower is taking concrete steps to build responsibly and unlock new infrastructure and product layers for the next generation of global commerce,” said Lawrence Tan, CEO of iPower Inc. Digital Asset Treasury Strategy with...

Continue reading

Achieve Life Sciences to Participate in the BTIG Virtual Biotechnology Conference

SEATTLE and VANCOUVER, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence for smoking cessation, today announced that the company will participate in the BTIG Virtual Biotechnology Conference being held July 29-30, 2025. Rick Stewart, Chief Executive Officer of Achieve, will participate in a fireside chat with Julian Harrison, BTIG Biotechnology Analyst, on Tuesday, July 29, at 3:20 pm EDT. For more information or to register for the conference, please email BTIG at uscorporateaccess@btig.com. About Achieve Life Sciences, Inc. Achieve Life Sciences is a late-stage specialty pharmaceutical company committed to addressing the global...

Continue reading

Global-e to Announce Financial Results for the Second Quarter 2025 on August 13, 2025

PETAH-TIKVA, Israel, July 29, 2025 (GLOBE NEWSWIRE) — Global-e Online Ltd. (Nasdaq: GLBE), the platform powering global direct-to-consumer e-commerce, today announced it will report financial results for the second quarter ended June 30, 2025, before market open on Wednesday, August 13, 2025. Global-e management will host a conference call to review its financial results and outlook.Date: Wednesday, August 13, 2025Time: 8:00 AM ETUnited States/Canada Toll Free: +1-800-717-1738International Toll: +1-646-307-1865Please join the call 5-10 minutes prior to the scheduled start time, to avoid a delay in connecting. A live webcast will be available in the Investor Relations section of Global-e’s website at https://investors.global-e.com/news-events/events-presentations A replay of the webcast will be available in the Investor...

Continue reading

AmpliTech Group Poised to Benefit from U.S. – EU Semiconductor Trade Deal

HAUPPAUGE, N.Y., July 29, 2025 (GLOBE NEWSWIRE) — AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today announces that it expects significant growth opportunities for its AGMDC and Spectrum Semiconductor Materials divisions following President Trump’s newly established trade deal with the European Union aimed at strengthening semiconductor chip manufacturing in the United States. The trade deal is designed to accelerate onshore semiconductor production, fostering a stronger domestic supply chain and reducing dependence on foreign sources. As U.S.-based...

Continue reading

Quoin Pharmaceuticals Provides Product Portfolio Update

Lead Product, QRX003, Being Tested in Two Active Registrational Clinical Studies for Netherton Syndrome Across the U.S., Europe, and the Middle East. QRX003 Peeling Skin Syndrome Clinical Program Continues Following Positive Initial Data Topical Rapamycin Development Programs Advancing Using Two Proprietary Delivery Technologies ASHBURN, Va., July 29, 2025 (GLOBE NEWSWIRE) — Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a late clinical stage specialty pharmaceutical company focused on rare and orphan diseases, today provided an updated overview of its development product portfolio. The company’s lead product, QRX003 for Netherton Syndrome (NS), continues to advance in two pivotal registrational clinical studies. The studies are being conducted at clinical sites in the US, Europe and the Middle East. In each...

Continue reading

BIGG Digital Assets provides Treasury and H1 2025 Update; Adds Jonathan Vlassopulos, former VP at Roblox and former CEO Napster, as Board Advisor

VANCOUVER, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) — BIGG Digital Assets Inc. (“BIGG” or the “Company”) (TSXV: BIGG; OTCQB: BBKCF; WKN: A2PS9W), is a leading innovator in the digital assets space and owner of Netcoins, Blockchain Intelligence Group, and TerraZero. At July 28, 2025, BIGG’s aggregate treasury was $24.9M, comprised of cash and cash equivalents of $6.3M and cryptocurrency valued at $18.6M, of which 65% is Bitcoin. The Company has been a long-term holder of Bitcoin on its balance sheet, dating back to its formation in 2017. The Company has no debt. BIGG’s cash and cryptocurrency treasury is used primarily by Netcoins. Our cryptocurrency is used for trading float and inventory, supporting a trading volume of $556 Million during the first half of 2025. As Netcoins’ trading volume increases, BIGG will add further...

Continue reading

IMUNON to Hold Second Quarter 2025 Financial Results and Business Update Conference Call on Tuesday, August 5, 2025

LAWRENCEVILLE, N.J., July 29, 2025 (GLOBE NEWSWIRE) — IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in late-stage development with its DNA-mediated immunotherapy, announces that the Company will host a conference call at 11:00 a.m. ET on Tuesday, August 5, 2025 to discuss financial results for the second quarter ended June 30, 2025 and provide an update on its clinical development program with IMNN-001, a DNA-based interleukin-12 (IL-12) immunotherapy, including progress in advancing the IMNN-001 development program in a Phase 3 clinical trial in advanced ovarian cancer. To participate in the call, interested parties may dial 833-816-1132 (Toll-Free/North America) or 412-317-0711 (International/Toll) and ask for the IMUNON Second Quarter 2025 Financial Results Call. A live webcast of the call will also be available here. The...

Continue reading

REAlloys Appoints Canada’s former Ambassador to the United States David MacNaughton to Corporate Board of Directors

DALLAS, July 29, 2025 (GLOBE NEWSWIRE) — Blackboxstocks Inc. (NASDAQ: BLBX), (“Blackbox” or the “Company”), announces that its merger target REalloys Inc. (“REA” or “REalloys”) a vertically integrated critical mineral company, today announced the appointment of David MacNaughton, Canada’s former Ambassador to the US, to its Corporate Board of Directors. David MacNaughton served as Canada’s ambassador to the United States from 2016 to 2019 during the first Trump Administration. Ambassador MacNaughton successfully represented Canadian interests in the complex negotiations leading to the 2020 United States-Mexico-Canada Agreement (USMCA). The USMCA, which substituted the North America Free Trade Agreement (NAFTA) and was a mutually beneficial win for North American workers, farmers, ranchers, and businesses, created a more balanced,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.